LENSAR, Inc. (LNSR)
Largest Insider Buys in Sector
LNSR Stock Price History Chart
LNSR Stock Performance
About LENSAR, Inc.
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company was incorporated in 2004 and is headquartered in Orlando, Florida.
Insider Activity of LENSAR, Inc.
Over the last 12 months, insiders at LENSAR, Inc. have bought $29,944 and sold $0 worth of LENSAR, Inc. stock.
On average, over the past 5 years, insiders at LENSAR, Inc. have bought $76,158 and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Winer Gary M (director) — $59,889.
The last purchase of 685 shares for transaction amount of $3,083 was made by Winer Gary M (director) on 2024‑09‑03.
List of Insider Buy and Sell Transactions, LENSAR, Inc.
| 2024-09-03 | director | 685 0.0057% | $4.50 | $3,083 | +1.30% | |||
| 2024-08-28 | director | 1,000 0.0082% | $4.45 | $4,450 | -0.21% | |||
| 2024-08-27 | director | 500 0.0042% | $4.50 | $2,250 | +0.43% | |||
| 2024-08-26 | director | 802 0.007% | $4.58 | $3,673 | +2.42% | |||
| 2024-08-22 | director | 2 <0.0001% | $4.30 | $9 | +5.91% | |||
| 2024-08-21 | director | 500 0.0043% | $4.35 | $2,176 | +3.79% | |||
| 2024-08-20 | director | 500 0.0045% | $4.20 | $2,100 | +14.53% | |||
| 2024-08-16 | director | 6 <0.0001% | $4.03 | $24 | -1.90% | |||
| 2024-08-14 | director | 1,000 0.0087% | $4.20 | $4,200 | 0.00% | |||
| 2024-08-12 | director | 500 0.0042% | $4.03 | $2,015 | +9.81% | |||
| 2023-11-22 | director | 300 0.0024% | $2.10 | $630 | +82.17% | |||
| 2023-11-16 | director | 1,000 0.0088% | $2.13 | $2,125 | +94.39% | |||
| 2023-11-15 | director | 500 0.0044% | $2.15 | $1,075 | +90.60% | |||
| 2023-11-10 | director | 1,000 0.0083% | $2.13 | $2,135 | +82.03% | |||
| 2023-08-11 | director | 705 0.0063% | $3.60 | $2,538 | -4.86% | |||
| 2023-08-10 | director | 1,000 0.0089% | $3.66 | $3,660 | -7.05% | |||
| 2023-05-22 | director | 16,647 0.1515% | $2.75 | $45,779 | +18.09% | |||
| 2023-05-19 | director | 22,153 0.2133% | $2.59 | $57,376 | +32.67% | |||
| 2023-05-18 | director | 7,700 0.071% | $2.61 | $20,097 | +25.95% | |||
| 2023-05-17 | director | 3,500 0.0316% | $2.29 | $8,015 | +40.08% |
Insider Historical Profitability
| Winer Gary M | director | 80840 0.6964% | $5.78 | 21 | 0 | <0.0001% |
| PDL BIOPHARMA, INC. | 10 percent owner | 8667397 74.6649% | $5.78 | 1 | 0 | |
| STAAB THOMAS R II | Chief Financial Officer | 135131 1.1641% | $5.78 | 2 | 0 | <0.0001% |
| WEISNER AIMEE S | director | 54285 0.4676% | $5.78 | 4 | 0 | +29.2% |
Institutional Investor Ownership
| Park West Asset Management Llc | $3.69M | 9.54 | 1.09M | -2.56% | -$97,045.50 | 0.28 | |
| Dimensional Fund Advisors | $2.34M | 5.77 | 657,864 | -0.43% | -$10,003.90 | <0.01 | |
| The Vanguard Group | $1.47M | 3.8 | 433,474 | 0% | +$0 | <0.0001 | |
| Brandes Investment Partners | $1.17M | 2.9 | 330,948 | +46% | +$370,165.47 | 0.02 | |
| Renaissance Technologies | $1.11M | 2.88 | 328,345 | +4.42% | +$47,225.65 | <0.01 |